1![CONTINUING CONCERNS OVER IMPORTED PHARMACEUTICALS HEARING BEFORE THE CONTINUING CONCERNS OVER IMPORTED PHARMACEUTICALS HEARING BEFORE THE](https://www.pdfsearch.io/img/2d5a5a68a6276086235b5bc1d75a1636.jpg) | Add to Reading ListSource URL: house.resource.orgLanguage: English - Date: 2010-10-22 14:00:55
|
---|
2![Guidance for Industry Reporting Drug Sample Information Under Section 6004 of the Affordable Care Act DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Guidance for Industry Reporting Drug Sample Information Under Section 6004 of the Affordable Care Act DRAFT GUIDANCE This guidance document is being distributed for comment purposes only.](https://www.pdfsearch.io/img/71cb354af513701686877bd06e3a1f96.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
3![RepliGen Sandford D. Smith President and Chief Executive 01ficer Repligen Corporation RepliGen Sandford D. Smith President and Chief Executive 01ficer Repligen Corporation](https://www.pdfsearch.io/img/7ddd83af4c2f52ac07a44eb78e513d79.jpg) | Add to Reading ListSource URL: www.clintonlibrary.govLanguage: English - Date: 2014-06-13 22:34:43
|
---|
4![United States Government Accountability Office GAO Report to Congressional Requesters United States Government Accountability Office GAO Report to Congressional Requesters](https://www.pdfsearch.io/img/f4550d689c6e0041ea803e2b359a8b21.jpg) | Add to Reading ListSource URL: pharmwatch.orgLanguage: English - Date: 2007-02-14 06:08:54
|
---|
5![Microsoft Word - Stat_Controlled Substances and Legend Drugs.doc Microsoft Word - Stat_Controlled Substances and Legend Drugs.doc](https://www.pdfsearch.io/img/10a257f1d58d68a111a9c06e5f4640b9.jpg) | Add to Reading ListSource URL: pharmacyboard.arkansas.govLanguage: English - Date: 2014-09-05 17:19:18
|
---|
6![Guidance for Industry Submitting Separate Marketing Applications and Clinical Data for Purposes of Assessing User Fees Guidance for Industry Submitting Separate Marketing Applications and Clinical Data for Purposes of Assessing User Fees](https://www.pdfsearch.io/img/7330131728d9741c2cbbb53d104410cc.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
7![Health / Pharmacology / Pharmaceutical industry / Marketing / Clinical pharmacology / Prescription Drug Marketing Act / Title 21 CFR Part 11 / Prescription medication / Food and Drug Administration / Pharmaceuticals policy / Pharmaceutical sciences / Medicine Health / Pharmacology / Pharmaceutical industry / Marketing / Clinical pharmacology / Prescription Drug Marketing Act / Title 21 CFR Part 11 / Prescription medication / Food and Drug Administration / Pharmaceuticals policy / Pharmaceutical sciences / Medicine](/pdf-icon.png) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2003-09-17 11:18:13
|
---|
8![725 15th Street, NW 4 Suite 700 b Washington, DC[removed][removed]l-888-USBLOOD 4 FAX[removed]WebSite:http://www.americasblood.org 4 e-mail:[removed] October 6,200O Docket No. 92N-0297 Dockets Mana 725 15th Street, NW 4 Suite 700 b Washington, DC[removed][removed]l-888-USBLOOD 4 FAX[removed]WebSite:http://www.americasblood.org 4 e-mail:[removed] October 6,200O Docket No. 92N-0297 Dockets Mana](https://www.pdfsearch.io/img/25df07059e137a5ad002c7a70e47c9da.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2000-10-26 12:14:21
|
---|
9![International Academy of Compounding Pharmacists P.O. Box 1365 Sugar Land, Texas[removed] International Academy of Compounding Pharmacists P.O. Box 1365 Sugar Land, Texas[removed]](https://www.pdfsearch.io/img/971ebbea7391aa9c25b6275557b1df33.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2000-10-26 13:06:12
|
---|
10![Pharmaceutical Statement of the Research and Manufacturers of America Pharmaceutical Statement of the Research and Manufacturers of America](https://www.pdfsearch.io/img/94d715562a1824d4f1ef42f18c2e9e4a.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2000-11-16 00:49:41
|
---|